Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation.

[1]  D. Cook,et al.  Lectin immunoassay for macrophage-activating factor (Gc-MAF) produced by deglycosylation of Gc-globulin: evidence for noninducible generation of Gc-MAF. , 2000, Clinical chemistry.

[2]  K. Ohkura,et al.  Elucidation of strict structural requirements of brefeldin A as an inducer of differentiation and apoptosis. , 2000, Bioorganic & medicinal chemistry.

[3]  H. Nagasawa,et al.  Apoptosis induction in HCT116 cells by cytochalasins isolated from the fungus Daldinia vernicosa. , 2000, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[4]  D. Wakefield,et al.  Abundant expression of chemokines in malignant and infective human lymphadenopathies. , 1999, Cytokine.

[5]  M. Páez de la Cadena,et al.  N-Acetyl-β-Hexosaminidase Activity and Isoenzymes in Human Gastric Adenocarcinoma , 1999, Oncology.

[6]  N. Yamamoto,et al.  Antitumor Effect of Vitamin D-Binding Protein-Derived Macrophage Activating Factor on Ehrlich Ascites Tumor-Bearing Mice , 1999 .

[7]  R. Beavis,et al.  Structural studies of alpha-N-acetylgalactosaminidase: effect of glycosylation on the level of expression, secretion efficiency, and enzyme activity. , 1998, Archives of biochemistry and biophysics.

[8]  N. Yamamoto,et al.  Deglycosylation of serum vitamin D3-binding protein by alpha-N-acetylgalactosaminidase detected in the plasma of patients with systemic lupus erythematosus. , 1997, Clinical immunology and immunopathology.

[9]  M. Páez de la Cadena,et al.  Alterations of glycosidases in human colonic adenocarcinoma. , 1997, Clinical biochemistry.

[10]  N. Yamamoto,et al.  Prognostic utility of serum alpha-N-acetylgalactosaminidase and immunosuppression resulted from deglycosylation of serum Gc protein in oral cancer patients. , 1997, Cancer research.

[11]  N. Yamamoto.  Structural definition of a potent macrophage activating factor derived from vitamin D3-binding protein with adjuvant activity for antibody production. , 1996, Molecular immunology.

[12]  R. Ray.  Molecular Recognition in Vitamin D-Binding Protein , 1996, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[13]  S. Asbell,et al.  Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in cancer patients. , 1996, Cancer research.

[14]  T. Kudo,et al.  Synthesis and activity of 1-N-iminosugar inhibitors, siastatin B analogues for alpha-N-acetylgalactosaminidase and beta-N-acetylglucosaminidase. , 1996, Bioorganic & medicinal chemistry.

[15]  I. Yamamoto,et al.  Enzymatically modified Gc globulin induces the translocation of Fc.GAMMA.R I and Fc.GAMMA.RII from intracellular storage compartments to the cell surface in murine peritoneal macrophages. , 1995 .

[16]  R. Frairia,et al.  The hepatic receptor for sex steroid-binding protein: study on a non-malignant cell line (Chang liver). , 1993, Journal of molecular endocrinology.

[17]  S. Josephs,et al.  Regulation of HIV-1 LTR trans-activating activities in two different human hepatocellular carcinoma cell lines. , 1993, Cancer letters.

[18]  R. Desnick,et al.  Overexpression of human alpha-galactosidase A results in its intracellular aggregation, crystallization in lysosomes, and selective secretion , 1992, The Journal of cell biology.

[19]  R. Desnick,et al.  Structural organization and complete sequence of the human alpha-N-acetylgalactosaminidase gene: homology with the alpha-galactosidase A gene provides evidence for evolution from a common ancestral gene. , 1991, Genomics.

[20]  Anne M. Wang,et al.  Schindler disease: the molecular lesion in the alpha-N-acetylgalactosaminidase gene that causes an infantile neuroaxonal dystrophy. , 1990, The Journal of clinical investigation.

[21]  I. Goldstein,et al.  Glycosidases of ehrlich ascites tumor cells and ascitic fluid—Purification and substrate specificity of α-N-Acetylgalactosaminidase and α-galactosidase: Comparison with coffee bean α-galactosidase , 1990 .

[22]  I. Goldstein,et al.  Glycosidases of Ehrlich ascites tumor cells and ascitic fluid--purification and substrate specificity of alpha-N-acetylgalactosaminidase and alpha-galactosidase: comparison with coffee bean alpha-galactosidase. , 1990, Archives of biochemistry and biophysics.

[23]  S. Tsuji.  Molecular cloning of a full-length cDNA for human ?-N-acetylgalactosaminidase (?-galactosidase B) , 1989 .

[24]  Anne M. Wang,et al.  Neuroaxonal Dystrophy Due to Lysosomal α-N-Acetylgalactosaminidase Deficiency , 1989 .

[25]  R. Desnick,et al.  Neuroaxonal dystrophy due to lysosomal alpha-N-acetylgalactosaminidase deficiency. , 1989, The New England journal of medicine.

[26]  K. Sakimura,et al.  Molecular cloning of a full-length cDNA for human alpha-N-acetylgalactosaminidase (alpha-galactosidase B). , 1989, Biochemical and Biophysical Research Communications - BBRC.

[27]  J. Montreuil,et al.  Isolation and characterization of the O-glycan chain of the human vitamin-D binding protein. , 1983, Biochemical and biophysical research communications.

[28]  R. Schultz,et al.  Macrophage activation and antitumor activity of a Brucella abortus ether extract, Bru-Pel. , 1978, Cancer treatment reports.

[29]  Z. Cohn,et al.  Increased superoxide anion production by immunologically activated and chemically elicited macrophages , 1978, The Journal of experimental medicine.

[30]  E. Davidson,et al.  Purification and properties of an endo-alpha-N-acetyl-D-galactosaminidase from Diplococcus pneumoniae. , 1977, The Journal of biological chemistry.

[31]  Chang Rs.  Continuous subcultivation of epithelial-like cells from normal human tissues. , 1954 .

[32]  J. Snyder,et al.  Continuous Subcultivation of Epithelial-like Cells from Normal Human Tissues.∗ , 1954, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.